Sponsor:
Candel Therapeutics, Inc.
Code:
NCT07332000
Conditions
Prostate Cancer Patients Treated by Radiotherapy
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
aglatimagene besadenovec + valacyclovir
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-19. This information was provided to ClinicalTrials.gov by Candel Therapeutics, Inc. on 2026-01-12.